191 related articles for article (PubMed ID: 31225721)
21. Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP-Activated Protein Kinase Signaling Pathway.
Lan T; Yu Y; Zhang J; Li H; Weng Q; Jiang S; Tian S; Xu T; Hu S; Yang G; Zhang Y; Wang W; Wang L; Zhu Q; Rong X; Guo J
Hepatology; 2021 Aug; 74(2):686-703. PubMed ID: 33576035
[TBL] [Abstract][Full Text] [Related]
22. Lycopene protects against pressure overload-induced cardiac hypertrophy by attenuating oxidative stress.
Zeng J; Zhao J; Dong B; Cai X; Jiang J; Xue R; Yao F; Dong Y; Liu C
J Nutr Biochem; 2019 Apr; 66():70-78. PubMed ID: 30772766
[TBL] [Abstract][Full Text] [Related]
23. Isoliquiritigenin attenuates pathological cardiac hypertrophy via regulating AMPKα in vivo and in vitro.
Gao M; Cai Q; Si H; Shi S; Wei H; Lv M; Wang X; Dong T
J Mol Histol; 2022 Aug; 53(4):679-689. PubMed ID: 35834120
[TBL] [Abstract][Full Text] [Related]
24. Gallic Acid Suppresses Cardiac Hypertrophic Remodeling and Heart Failure.
Yan X; Zhang YL; Zhang L; Zou LX; Chen C; Liu Y; Xia YL; Li HH
Mol Nutr Food Res; 2019 Mar; 63(5):e1800807. PubMed ID: 30521107
[TBL] [Abstract][Full Text] [Related]
25. Cordycepin, 3'-deoxyadenosine, prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression.
Park ES; Kang DH; Yang MK; Kang JC; Jang YC; Park JS; Kim SK; Shin HS
Cardiovasc Toxicol; 2014 Mar; 14(1):1-9. PubMed ID: 24178833
[TBL] [Abstract][Full Text] [Related]
26. Vasonatrin peptide, a synthetic natriuretic peptide, attenuates myocardial injury and oxidative stress in isoprenaline-induced cardiomyocyte hypertrophy.
Chang P; Zhang X; Chen W; Zhang J; Wang J; Wang X; Yu J; Zhu X
Peptides; 2021 Mar; 137():170474. PubMed ID: 33359394
[TBL] [Abstract][Full Text] [Related]
27. Zingerone attenuates aortic banding-induced cardiac remodelling via activating the eNOS/Nrf2 pathway.
Liu C; Wu QQ; Cai ZL; Xie SY; Duan MX; Xie QW; Yuan Y; Deng W; Tang QZ
J Cell Mol Med; 2019 Sep; 23(9):6466-6478. PubMed ID: 31293067
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism.
Guo L; Yin A; Zhang Q; Zhong T; O'Rourke ST; Sun C
Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H980-H991. PubMed ID: 28411231
[TBL] [Abstract][Full Text] [Related]
29. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.
Fang X; Liu Y; Lu J; Hong H; Yuan J; Zhang Y; Wang P; Liu P; Ye J
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1373-1385. PubMed ID: 30132020
[TBL] [Abstract][Full Text] [Related]
30. Sanggenon C protects against pressure overload‑induced cardiac hypertrophy via the calcineurin/NFAT2 pathway.
Xiao L; Gu Y; Gao L; Shangguan J; Chen Y; Zhang Y; Li L
Mol Med Rep; 2017 Oct; 16(4):5338-5346. PubMed ID: 28849031
[TBL] [Abstract][Full Text] [Related]
31. Maslinic acid protects against pressure overload-induced cardiac hypertrophy in mice.
Liu YL; Kong CY; Song P; Zhou H; Zhao XS; Tang QZ
J Pharmacol Sci; 2018 Oct; 138(2):116-122. PubMed ID: 30389277
[TBL] [Abstract][Full Text] [Related]
32. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
[TBL] [Abstract][Full Text] [Related]
33. Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway.
Cai J; Yi FF; Bian ZY; Shen DF; Yang L; Yan L; Tang QZ; Yang XC; Li H
J Cell Mol Med; 2009 May; 13(5):909-25. PubMed ID: 19413885
[TBL] [Abstract][Full Text] [Related]
34. Omentin functions to attenuate cardiac hypertrophic response.
Matsuo K; Shibata R; Ohashi K; Kambara T; Uemura Y; Hiramatsu-Ito M; Enomoto T; Yuasa D; Joki Y; Ito M; Hayakawa S; Ogawa H; Kihara S; Murohara T; Ouchi N
J Mol Cell Cardiol; 2015 Feb; 79():195-202. PubMed ID: 25479337
[TBL] [Abstract][Full Text] [Related]
35. Astragaloside IV Prevents Cardiac Remodeling in the Apolipoprotein E-Deficient Mice by Regulating Cardiac Homeostasis and Oxidative Stress.
Li XZ; Ding YZ; Wu HF; Bian ZP; Xu JD; Gu CR; Chen XJ; Yang D
Cell Physiol Biochem; 2017; 44(6):2422-2438. PubMed ID: 29268252
[TBL] [Abstract][Full Text] [Related]
36. Cinnamaldehyde attenuates pressure overload-induced cardiac hypertrophy.
Yang L; Wu QQ; Liu Y; Hu ZF; Bian ZY; Tang QZ
Int J Clin Exp Pathol; 2015; 8(11):14345-54. PubMed ID: 26823750
[TBL] [Abstract][Full Text] [Related]
37. High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K/Akt pathway.
Lin L; Liu X; Xu J; Weng L; Ren J; Ge J; Zou Y
J Cell Mol Med; 2015 Aug; 19(8):1929-38. PubMed ID: 25946687
[TBL] [Abstract][Full Text] [Related]
38. Melatonin protects against the pathological cardiac hypertrophy induced by transverse aortic constriction through activating PGC-1β: In vivo and in vitro studies.
Zhai M; Liu Z; Zhang B; Jing L; Li B; Li K; Chen X; Zhang M; Yu B; Ren K; Yang Y; Yi W; Yang J; Liu J; Yi D; Liang H; Jin Z; Reiter RJ; Duan W; Yu S
J Pineal Res; 2017 Oct; 63(3):. PubMed ID: 28708271
[TBL] [Abstract][Full Text] [Related]
39. Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes.
Liu BY; Li L; Liu GL; Ding W; Chang WG; Xu T; Ji XY; Zheng XX; Zhang J; Wang JX
Acta Pharmacol Sin; 2021 May; 42(5):701-714. PubMed ID: 32796955
[TBL] [Abstract][Full Text] [Related]
40. Geniposide Protects against Obesity-Related Cardiac Injury through AMPK
Ma ZG; Kong CY; Song P; Zhang X; Yuan YP; Tang QZ
Oxid Med Cell Longev; 2018; 2018():6053727. PubMed ID: 30533173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
